The nation of Zimbabwe has declined a significant US healthcare agreement worth $367m (£272m) spanning five years over the United States' request for sensitive data.
This rejection became public following a official document dated December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the arrangement was "lopsided".
A government spokesperson has since explained that the United States was seeking genetic material for research and profit while refused to share the benefits from any future treatments.
"We will now turn to the difficult and regrettable process of winding down our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had provided more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has called for further negotiations to reach a deal suitable to both sides so the country's critical HIV treatment initiative can be sustained.
Wider Context
Zimbabwe's decision follows a comparable situation in neighbouring Kenya, where a court suspended a similar deal with the US following legal challenges were raised about the security of citizens' medical information.
Since returning to office recently, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
USAID had administered aid for the American government, but Trump stated its spending was "wasteful" and his administration was seeking direct bilateral deals to boost transparency and responsibility.
According to statements, 16 African countries have to date agreed to these new health pacts, constituting more than $18.3bn in committed funds.
Details of the Declined Deal
This assistance for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".
"It is our view this cooperation might have yielded immense benefits for Zimbabwean communities, especially the 1.2 million presently receiving antiretroviral therapy via American-funded initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana maintained the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to provide its biological resources and data over an extended period, without any equivalent guarantee of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that provided information," he stated.
"Put simply, our country would provide the basic resources for scientific discovery without any certainty that the end products would be available to our citizens if a future health crisis arise."
Sovereignty and Global Health
He also noted that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were upending structures previously set up through the international health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing system designed to manage future pandemics.
"This framework is designed to guarantee that when a nation contributes its data, the benefits – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to develop them."
The government's concerns regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We are open to ongoing discussions with our American counterparts on how subsequent collaboration could be designed in a way that honours the independence and interests of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but urged that negotiations should continue considering a large portion of the nation's HIV programmes relied on external financing.
"If technical issues arise, such as those involving information security or implementation frameworks, these can frequently be addressed via technical clarification and mutually agreed protections," it said.
This impasse emphasises the ongoing challenges between accepting crucial international aid and safeguarding a country's data in an ever more interconnected world.